

Here's a roundup of top developments in the biotech space over the last 24 hours:
You can purchase shares of SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB (OTCPK:BIOVF) through any online brokerage.
There are no as such competitors for SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB.
There is no analysis for SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB to provide a consensus price target.
The stock price for SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB (OTCPK: BIOVF) is $51.05 last updated November 9, 2026 at 2:56 PM EST.
There are no upcoming dividends for SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB.
SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB does not have any upcoming earnings scheduled.
There is no upcoming split for SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB.
SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in...